Log in

Centrus Energy Stock Forecast, Price & News

+0.22 (+2.11 %)
(As of 10/23/2020 12:00 AM ET)
Today's Range
Now: $10.66
50-Day Range N/A
52-Week Range
Now: $10.66
Volume97,014 shs
Average Volume86,615 shs
Market Capitalization$118.68 million
P/E RatioN/A
Dividend YieldN/A
Centrus Energy Corp. supplies nuclear fuel and services for the nuclear power industry in the United States, Japan, Belgium, and internationally. The company operates in two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) component of LEU; SWU and uranium components of LEU; and natural uranium for utilities that operate nuclear power plants. Its LEU is a component that is used in the production of nuclear fuel for reactors to produce electricity. The Technical Solutions segment offers technical, manufacturing, engineering, procurement, construction, and operations services to public and private sector customers, including the American Centrifuge engineering and testing activities. The company was formerly known as USEC Inc. and changed its name to Centrus Energy Corp. in September 2014. Centrus Energy Corp. was founded in 1998 and is headquartered in Bethesda, Maryland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.86 out of 5 stars

Industry, Sector and Symbol

Industry Industrial Metals & Minerals
Previous SymbolNYSEMKT:LEU



Sales & Book Value

Annual SalesN/A



Market Cap$118.68 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
+0.22 (+2.11 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LEU News and Ratings via Email

Sign-up to receive the latest news and ratings for LEU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Centrus Energy (NYSEAMERICAN:LEU) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Centrus Energy?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centrus Energy in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Centrus Energy

When is Centrus Energy's next earnings date?

Centrus Energy is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Centrus Energy

How were Centrus Energy's earnings last quarter?

Centrus Energy Corp. (NYSEAMERICAN:LEU) posted its quarterly earnings results on Tuesday, August, 4th. The basic materials company reported $3.19 earnings per share (EPS) for the quarter. The basic materials company earned $75.70 million during the quarter.
View Centrus Energy's earnings history

What price target have analysts set for LEU?

3 brokerages have issued 1 year price objectives for Centrus Energy's stock. Their forecasts range from $16.00 to $18.00. On average, they anticipate Centrus Energy's stock price to reach $17.00 in the next year. This suggests a possible upside of 59.5% from the stock's current price.
View analysts' price targets for Centrus Energy

Are investors shorting Centrus Energy?

Centrus Energy saw a increase in short interest in September. As of September 30th, there was short interest totaling 114,000 shares, an increase of 14.9% from the September 15th total of 99,200 shares. Based on an average daily volume of 166,200 shares, the short-interest ratio is currently 0.7 days.
View Centrus Energy's Short Interest

Who are some of Centrus Energy's key competitors?

What other stocks do shareholders of Centrus Energy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Centrus Energy investors own include Ampio Pharmaceuticals (AMPE), Arbutus Biopharma (ABUS), Aeterna Zentaris (AEZS), Align Technology (ALGN), CTI BioPharma (CTIC), CEL-SCI (CVM), Genocea Biosciences (GNCA), Palatin Technologies (PTN), Vascular Biogenics (VBLT) and Agenus (AGEN).

Who are Centrus Energy's key executives?

Centrus Energy's management team includes the following people:
  • Mr. Daniel B. Poneman, CEO, Pres & Director (Age 64, Pay $1.56M)
  • Mr. Elmer W. Dyke, Exec. VP of LEU Operations & Corp. Bus. Devel. (Age 56, Pay $653.88k)
  • Mr. Philip O. Strawbridge, Sr. VP, CFO, Chief Admin. Officer & Treasurer (Age 65)
  • Mr. John C. Dorrian, Controller & Chief Accounting Officer (Age 56)
  • Mr. Don Hatcher, Director of Investor Relations

What is Centrus Energy's stock symbol?

Centrus Energy trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "LEU."

Who are Centrus Energy's major shareholders?

Centrus Energy's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Sara Bay Financial (3.23%) and Guild Investment Management Inc. (0.83%).
View institutional ownership trends for Centrus Energy

Which major investors are buying Centrus Energy stock?

LEU stock was purchased by a variety of institutional investors in the last quarter, including Sara Bay Financial, and Guild Investment Management Inc..
View insider buying and selling activity for Centrus Energy

How do I buy shares of Centrus Energy?

Shares of LEU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Centrus Energy's stock price today?

One share of LEU stock can currently be purchased for approximately $10.66.

How big of a company is Centrus Energy?

Centrus Energy has a market capitalization of $118.68 million. Centrus Energy employs 230 workers across the globe.

What is Centrus Energy's official website?

The official website for Centrus Energy is www.centrusenergy.com.

How can I contact Centrus Energy?

The basic materials company can be reached via phone at 301-564-3200.

This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.